首页> 外文期刊>ACS medicinal chemistry letters >Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure
【24h】

Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure

机译:具有氧杂三环癸烷结构的新型Delta阿片受体激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

We synthesized compounds 4a,c-f,h,i containing the oxazatricyclodecane structure from a novel rearrangement reaction product 2a. All the prepared compounds 4a,c-f,h,i exhibited full agonistic activities for the δ opioid receptor (DOR). Among them, the N-methyl derivative 4c was highly selective, and the most effective DOR agonist in functional assays. Subcutaneous administration of 4c produced dose-dependent and NTI (selective DOR antagonist)- reversible antinociception lacking any convulsive behaviors in the mice acetic acid writhing tests. The N-methyl derivative 4c is expected to be a promising lead compound for selective DOR agonists with a novel chemotype.
机译:我们从新型重排反应产物2a合成了含有氧杂三环癸烷结构的化合物4a,c-f,h,i。所有制备的化合物4a,c-f,h,i对δ阿片受体(DOR)表现出完全的激动活性。其中,N-甲基衍生物4c具有高度选择性,并且是功能测定中最有效的DOR激动剂。皮下给药4c可产生剂量依赖性和NTI(选择性DOR拮抗剂)可逆的抗伤害性,在小鼠醋酸扭体试验中缺乏任何惊厥行为。 N-甲基衍生物4c有望成为具有新型化学型的选择性DOR激动剂的有前途的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号